The administration has proposed steps such as funding increased production of testing supplies and ensuring schools have access to more frequent testing.
While the approach has been promoted as a tool for expanding testing capacity, high rates of infection and implementation challenges have led to low uptake.
The company launched in November a survey-based test for screening patients for preterm birth risk that it plans to pair with a mass spectrometry-based assay.
While some remain concerned that the bill will reduce labs' leverage with payors, provisions like the use of arbitration for disputes are a win for providers.
Demand for SARS-CoV-2 testing sent lab revenues soaring while changes in patterns of patient care and regulations that could have impacts for years to come.
While SARS-CoV-2 test demand will likely remain strong well into 2021, the question of what to do with the built-up capacity in a post-COVID-19 environment looms.
The company is using collaborations with several medical centers to explore how flexible robotics platforms could further automate the clinical laboratory.
With the EUA, LabCorp is able to sell the test kit directly to consumers without a prescription, making it the first over-the-counter COVID-19 test in the US.
